Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. N. Kosenko"'
Autor:
V. A. Evseenko, A. V. Zaykovskaya, A. S. Gudymo, O. S. Taranov, S. E. Olkin, A. R. Imatdinov, E. Yu. Prudnikova, N. V. Danilchenko, I. S. Shulgina, M. N. Kosenko, E. I. Danilenko, S. A. Pyankov, A. B. Ryzhikov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 530-543 (2023)
Scientific relevance. The use of recombinant antigens in vaccine production is limited because vaccines based on such antigens tend to have low immunogenicity. However, a COVID-19 vaccine that combines recombinant SARS-CoV-2 spike glycoprotein as its
Externí odkaz:
https://doaj.org/article/04f5c47f181c475a88f4a2d66be91651
